世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

世界の医療用フットウェア市場 2018-2022年

Global Medical Footwear Market 2018-2022

IRTNTR22843

 

出版社 出版年月電子版価格 ページ数
TechNavio
テクナビオ
2018年8月US$2,500
シングルユーザライセンス
125

サマリー

この調査レポートは世界の医療用フットウェア市場を分析・予測したTechNavioの市場調査報告書です。

目次

PART 01: EXECUTIVE SUMMARY
PART 02: SCOPE OF THE REPORT
PART 03: RESEARCH METHODOLOGY
PART 04: MARKET LANDSCAPE
- Market outline
- Market ecosystem
- Market characteristics
- Market segmentation analysis
PART 05: MARKET SIZING
- Market definition
- Market sizing 2017
- Market size and forecast 2017-2022
PART 06: FIVE FORCES ANALYSIS
- Bargaining power of buyers
- Bargaining power of suppliers
- Threat of new entrants
- Threat of substitutes
- Threat of rivalry
- Market condition
PART 07: CUSTOMER LANDSCAPE
PART 08: MARKET SEGMENTATION BY DISTRIBUTION CHANNEL
- Segmentation by distribution channel
- Comparison by distribution channel
- Offline distribution channel - Market size and forecast 2017-2022
- Online distribution channel - Market size and forecast 2017-2022
- Market opportunity by distribution channel
PART 09: MARKET SEGMENTATION BY END-USER
- Segmentation by end-user
- Comparison by end-user
- Men - Market size and forecast 2017-2022
- Women - Market size and forecast 2017-2022
- Market opportunity by end-user
PART 10: REGIONAL LANDSCAPE
- Geographical segmentation
- Regional comparison
- Americas - Market size and forecast 2017-2022
- EMEA - Market size and forecast 2017-2022
- APAC - Market size and forecast 2017-2022
- Key leading countries
- Market opportunity
PART 11: DECISION FRAMEWORK
PART 12: DRIVERS AND CHALLENGES
- Market drivers
- Market challenges
PART 13: MARKET TRENDS
- Surge in innovative product designs
- Eco-friendly medical footwear
- Rise in product visibility and accessibility through online retailing
PART 14: VENDOR LANDSCAPE
- Overview
- Landscape disruption
- Competitive scenario
PART 15: VENDOR ANALYSIS
- Vendors covered
- Vendor classification
- Market positioning of vendors
- Aetrex Worldwide
- DJO Global
- Drew Shoe
- New Balance
- OrthoFeet
PART 16: APPENDIX
- List of abbreviations


Exhibit 01: Related market
Exhibit 02: Market characteristics
Exhibit 03: Market segments
Exhibit 04: Market definition - Inclusions and exclusions checklist
Exhibit 05: Market size 2017
Exhibit 06: Validation techniques employed for market sizing 2017
Exhibit 07: Global medical footwear market - Market size and forecast 2017-2022 ($ mn)
Exhibit 08: Global medical footwear market - Year-over-year growth 2018-2022 (%)
Exhibit 09: Five forces analysis 2017
Exhibit 10: Five forces analysis 2022
Exhibit 11: Bargaining power of buyers
Exhibit 12: Bargaining power of suppliers
Exhibit 13: Threat of new entrants
Exhibit 14: Threat of substitutes
Exhibit 15: Threat of rivalry
Exhibit 16: Market condition - Five forces 2017
Exhibit 17: Customer landscape
Exhibit 18: Distribution channel - Market share 2017-2022 (% share of revenue)
Exhibit 19: Comparison by distribution channel
Exhibit 20: Offline distribution channel - Market size and forecast 2017-2022 ($ mn)
Exhibit 21: Offline distribution channel - Year-over-year growth 2018-2022 (%)
Exhibit 22: Online distribution channel - Market size and forecast 2017-2022 ($ mn)
Exhibit 23: Online distribution channel? Year-over-year growth 2018-2022 (%)
Exhibit 24: Market opportunity by distribution channel
Exhibit 25: End-user - Market share 2017-2022 (% share of revenue)
Exhibit 26: Comparison by end-user
Exhibit 27: Men - Market size and forecast 2017-2022 ($ mn)
Exhibit 28: Men - Year-over-year growth 2018-2022 (%)
Exhibit 29: Women - Market size and forecast 2017-2022 ($ mn)
Exhibit 30: Women - Year-over-year growth 2018-2022 (%)
Exhibit 31: Market opportunity by end-user
Exhibit 32: Geography - Market share 2017-2022 (% share of revenue)
Exhibit 33: Regional comparison
Exhibit 34: Americas - Market size and forecast 2017-2022 ($ mn)
Exhibit 35: Diabetes prevalence in Americas in 2017
Exhibit 36: Americas - Year-over-year growth 2018-2022 (%)
Exhibit 37: Population aged 65 and above in US (total in millions)
Exhibit 38: Population aged 65 and above in Canada (total in millions)
Exhibit 39: Population aged 65 and above in Brazil (total in millions)
Exhibit 40: Household final consumption expenditure in US 2012-2016 ($ trillions)
Exhibit 41: Household final consumption expenditure in Canada 2012-2016 ($ trillions)
Exhibit 42: Household final consumption expenditure in Brazil 2012-2016 ($ trillions)
Exhibit 43: Top 3 countries in Americas
Exhibit 44: EMEA - Market size and forecast 2017-2022 ($ mn)
Exhibit 45: Diabetes prevalence in EMEA in 2017
Exhibit 46: EMEA - Year-over-year growth 2018-2022 (%)
Exhibit 47: Population aged 65 and above in Germany (total in millions)
Exhibit 48: Population aged 65 and above in UK (total in millions)
Exhibit 49: Population aged 65 and above in France (total in millions)
Exhibit 50: Household final consumption expenditure in Germany 2012-2016 ($ trillions)
Exhibit 51: Household final consumption expenditure in UK 2012-2016 ($ trillions)
Exhibit 52: Household final consumption expenditure in France 2012-2016 ($ trillions)
Exhibit 53: Top 3 countries in EMEA
Exhibit 54: APAC - Market size and forecast 2017-2022 ($ mn)
Exhibit 55: Diabetes prevalence in APAC in 2017
Exhibit 56: APAC - Year-over-year growth 2018-2022 (%)
Exhibit 57: Population aged 65 and above in China (total in millions)
Exhibit 58: Population aged 65 and above in Japan (total in millions)
Exhibit 59: Population aged 65 and above in South Korea (total in millions)
Exhibit 60: Household final consumption expenditure in China 2012-2016 ($ trillions)
Exhibit 61: Household final consumption expenditure in Japan 2012-2016 ($ trillions)
Exhibit 62: Household final consumption expenditure in South Korea 2012-2016 ($ trillions)
Exhibit 63: Top 3 countries in APAC
Exhibit 64: Key leading countries
Exhibit 65: Market opportunity
Exhibit 66: Life expectancy 2010-2014 - World and regions (years)
Exhibit 67: Healthy life expectancy (years) and years lived with disability or disease burden 2010-2016 - World
Exhibit 68: Median age (of overall population) 2010-2015 - World (years)
Exhibit 69: Population aged 65 and above, total in EU and US 2010-2017 (millions)
Exhibit 70: Global population ages 65 and above, total 2010-2017 (millions)
Exhibit 71: Global population ages 65 and above 2010-2017 (% of total)
Exhibit 72: Individuals using the Internet - Worldwide 2011-2016 (% of total population)
Exhibit 73: Global mobile cellular subscriptions 2011-2016 (per 100 people)
Exhibit 74: Vendor landscape
Exhibit 75: Landscape disruption
Exhibit 76: Vendors covered
Exhibit 77: Vendor classification
Exhibit 78: Market positioning of vendors
Exhibit 79: Aetrex Worldwide - Vendor overview
Exhibit 80: Aetrex Worldwide - Business segments
Exhibit 81: Aetrex Worldwide - Organizational developments
Exhibit 82: Aetrex Worldwide - Key offerings
Exhibit 83: DJO Global - Vendor overview
Exhibit 84: DJO Global - Business portfolio
Exhibit 85: DJO Global - Organizational developments
Exhibit 86: DJO Global - Key offerings
Exhibit 87: Drew Shoe - Vendor overview
Exhibit 88: Drew Shoe - Business segments
Exhibit 89: Drew Shoe - Organizational developments
Exhibit 90: Drew Shoe - Key offerings
Exhibit 91: New Balance - Vendor overview
Exhibit 92: New Balance - Business segments
Exhibit 93: New Balance - Organizational developments
Exhibit 94: New Balance - Key offerings
Exhibit 95: OrthoFeet - Vendor overview
Exhibit 96: OrthoFeet - Business segments
Exhibit 97: OrthoFeet - Organizational developments
Exhibit 98: OrthoFeet - Key offerings

 

ページTOPに戻る

あなたが最近チェックしたレポート一覧

  • 最近チェックしたレポートはありません。

お問合は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのお問合せはこちらのフォームから承ります

このレポートへのお問合せ

03-3582-2531

電話お問合せもお気軽に

<無料>メルマガに登録する

 

 

ページTOPに戻る